Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition

Olive S. Eckstein, Johannes Visser, Carlos Rodriguez-Galindo, Carl E. Allen and the NACHO-LIBRE Study Group
PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.